Gene therapy for diabetic peripheral neuropathy: A randomized, placebo‐controlled phase III study of VM202, a plasmid DNA encoding human hepatocyte growth factor-Reference-Cited by-同舟云学术

Gene therapy for diabetic peripheral neuropathy: A randomized, placebo‐controlled phase III study of VM202, a plasmid DNA encoding human hepatocyte growth factor

Published:2021-02-02 Issue:3 Volume:14 Page:1176-1184
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clin Transl Sci

Author:

Kessler John A.¹,Shaibani Aziz²,Sang Christine N.³,Christiansen Mark⁴,Kudrow David⁵,Vinik Aaron⁶,Shin Nari⁷,

Affiliation:

1. Department of Neurology Northwestern University Chicago Illinois USA

2. Nerve and Muscle Center of Texas Texas Medical Center Houston Texas USA

3. Department of Neurology Brigham and Women's Hospital Boston Massachusetts USA

4. Diablo Clinical Research Center Walnut Creek California USA

5. Neurological Research Institute Santa Monica California USA

6. Strelitz Diabetes Center Eastern Virginia Medical School Norfolk Virginia USA

7. Helixmith Inc Seoul Korea

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.12977

Reference43 articles.

1. The Prevalence, Severity, and Impact of Painful Diabetic Peripheral Neuropathy in Type 2 Diabetes

2. The impact of neuropathic pain on health-related quality of life: Review and implications

3. Diabetic Neuropathy

4. Painful Diabetic Peripheral Neuropathy in a Managed Care Setting: Patient Identification, Prevalence Estimates, and Pharmacy Utilization Patterns

5. Association of Long-term Opioid Therapy With Functional Status, Adverse Outcomes, and Mortality Among Patients With Polyneuropathy

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioinformatics and systems biology approach to identify the pathogenetic link of neurological pain and major depressive disorder;Experimental Biology and Medicine;2024-06-27

2. A phase 1/2a, open label study to evaluate the safety and efficacy of a plasmid DNA encoding human hepatocyte growth factor in patients with Charcot-Marie-Tooth disease 1A;2024-06-14

3. Pathology of pain and its implications for therapeutic interventions;Signal Transduction and Targeted Therapy;2024-06-08

4. Therapeutic Effect of Schwann Cell-Like Cells Differentiated from Human Tonsil-Derived Mesenchymal Stem Cells on Diabetic Neuropathy in db/db Mice;Tissue Engineering and Regenerative Medicine;2024-04-15

5. Decrypting the multifaceted peripheral neuropathy based on molecular pathology and therapeutics: a comprehensive review;Archives of Physiology and Biochemistry;2024-04-08